MedPath

Innovative diagnostics and treatment of misophonia in children and adolescents: a new psychiatric disorder

Completed
Conditions
10037176
hatred of sound
misophonia
Registration Number
NL-OMON52247
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
322
Inclusion Criteria

Eligible for participation in the healthy control group for the validation
study are: children between the ages of 8 and 18 years old, without
psychopathological symptoms of misophonia, not having received treatment for
misophonia in the past year. Children and their parents should have provided
written informed consent.
Eligible for participation in the patient group of the validation study and the
RCT study of treatment effectivity are: children between the ages of 8 and 18
years old, referred to the Amsterdam UMC / Levvel for diagnosis and treatment
of misophonia, with treatment being indicated according to clinician, parents
and / or child. Children and their parents should have provided written
informed consent.

Exclusion Criteria

Validation study (healthy control group): meeting the criteria for misophonia
on a psychopathological level, needing treatment; having had the diagnosis of
misophonia and / or treatment for misophonia in the past year; mental
retardation (estimated IQ below 85 in children and / or parents); inability to
read / write or understand Dutch.
Validation study (patient group) and RCT study of treatment effectivity: not
meeting the inclusion criteria; does not have misophonia as primary problem
domain; having psychiatric comorbid symptoms or diagnosis that hinder group
functioning or require change of treatment protocol*; family problems that
hinder participation or adherence to treatment protocol*; having had cognitive
behavioral therapy for misophonia in the past year; self-injurious behavior
(i.e. automutilation) at present or in the past year; mental retardation
(estimated IQ below 85 in children and / or parents); inability to read / write
or understand Dutch.
* as assessed during the screening, during the intake (by a psychiatrist and/or
clinical psychologist), and by the questionnaires.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>(See also METC protocol)<br /><br><br /><br>The primary outcome of the study is the severity of misophonia symptoms, as<br /><br>measured by the AMISOS-Y.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>(See also METC protocol)<br /><br><br /><br>Secundary outcomes are:<br /><br>- Misophonia complaints (Misophonia Screening List - Child and Youth)<br /><br>- Psychopathology in the child (attention and concentration problems,<br /><br>anxiety/depression, oppositional behavior, compulsions)<br /><br>- Severity of psychopathology (change over time)<br /><br>- School functioning<br /><br>- Quality of life<br /><br>- Attention problems<br /><br>- Sensory processing<br /><br>- Care related quality of life<br /><br>- Cost of illness<br /><br>- Social validity of treatment<br /><br>- Family accommodation to misophonia<br /><br>- Coercive disruptive behavior child </p><br>
© Copyright 2025. All Rights Reserved by MedPath